FUKOKU MUTUAL LIFE INSURANCE Co Lowers Stock Position in Oracle Corporation $ORCL

FUKOKU MUTUAL LIFE INSURANCE Co cut its position in shares of Oracle Corporation (NYSE:ORCL) by 6.6% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 5,828 shares of the enterprise software provider’s stock after selling 412 shares during the quarter. FUKOKU MUTUAL LIFE INSURANCE Co’s holdings in Oracle were worth $1,274,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Lockheed Martin Investment Management Co. grew its stake in shares of Oracle by 4.3% during the 1st quarter. Lockheed Martin Investment Management Co. now owns 51,350 shares of the enterprise software provider’s stock worth $7,179,000 after acquiring an additional 2,110 shares during the period. Private Wealth Asset Management LLC lifted its holdings in Oracle by 9.2% during the second quarter. Private Wealth Asset Management LLC now owns 3,817 shares of the enterprise software provider’s stock valued at $835,000 after purchasing an additional 321 shares during the last quarter. Soltis Investment Advisors LLC boosted its position in Oracle by 4.8% during the second quarter. Soltis Investment Advisors LLC now owns 32,937 shares of the enterprise software provider’s stock worth $7,201,000 after purchasing an additional 1,515 shares during the period. Cascade Investment Group Inc. purchased a new position in shares of Oracle in the second quarter worth about $239,000. Finally, Lockerman Financial Group Inc. purchased a new position in shares of Oracle in the second quarter worth about $328,000. Hedge funds and other institutional investors own 42.44% of the company’s stock.

Analysts Set New Price Targets

Several research firms recently commented on ORCL. Cowen reaffirmed a “buy” rating on shares of Oracle in a report on Friday, October 17th. Berenberg Bank raised their price target on Oracle from $202.00 to $306.00 and gave the stock a “hold” rating in a report on Monday, September 15th. Redburn Partners set a $175.00 price target on Oracle in a research report on Thursday, September 25th. Barclays increased their price objective on Oracle from $367.00 to $400.00 and gave the stock an “overweight” rating in a report on Friday, October 17th. Finally, Stephens lifted their target price on Oracle from $208.00 to $331.00 and gave the company an “equal weight” rating in a report on Friday, October 17th. Three research analysts have rated the stock with a Strong Buy rating, twenty-seven have assigned a Buy rating, ten have assigned a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $322.26.

Oracle Price Performance

Shares of NYSE ORCL opened at $225.39 on Thursday. The stock’s 50-day simple moving average is $276.74 and its two-hundred day simple moving average is $235.39. Oracle Corporation has a twelve month low of $118.86 and a twelve month high of $345.72. The firm has a market capitalization of $642.54 billion, a P/E ratio of 52.17, a P/E/G ratio of 2.96 and a beta of 1.51. The company has a quick ratio of 0.62, a current ratio of 0.62 and a debt-to-equity ratio of 3.33.

Oracle (NYSE:ORCL) last issued its quarterly earnings data on Tuesday, September 9th. The enterprise software provider reported $1.47 EPS for the quarter, missing the consensus estimate of $1.48 by ($0.01). The business had revenue of $14.93 billion for the quarter, compared to analysts’ expectations of $15.04 billion. Oracle had a return on equity of 72.93% and a net margin of 21.08%.The firm’s revenue for the quarter was up 12.2% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.39 EPS. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. As a group, equities analysts anticipate that Oracle Corporation will post 5 EPS for the current fiscal year.

Oracle Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, October 23rd. Stockholders of record on Thursday, October 9th were issued a $0.50 dividend. The ex-dividend date of this dividend was Thursday, October 9th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.9%. Oracle’s dividend payout ratio is presently 46.30%.

Insider Activity

In other news, CEO Clayton M. Magouyrk sold 40,000 shares of Oracle stock in a transaction on Tuesday, October 21st. The shares were sold at an average price of $276.64, for a total transaction of $11,065,600.00. Following the completion of the sale, the chief executive officer directly owned 154,030 shares of the company’s stock, valued at approximately $42,610,859.20. The trade was a 20.62% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Naomi O. Seligman sold 2,222 shares of the company’s stock in a transaction on Friday, September 26th. The stock was sold at an average price of $288.91, for a total transaction of $641,958.02. Following the completion of the transaction, the director owned 29,225 shares of the company’s stock, valued at $8,443,394.75. This trade represents a 7.07% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders have sold 204,254 shares of company stock worth $60,227,807. Corporate insiders own 40.90% of the company’s stock.

Oracle Company Profile

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.